Our results distinguished FASN, FN, TFRC and TSC1 from previously identified tumour promoters and revealed novel prediction model IPRPs that outperformed the currently established prognostic parameters for anticipating disease course and better clinical management of adult ACC. This evidence concerns the gene FN1 and neoplasm.